Exicure Revenue

In the year 2024, Exicure had annual revenue of $500.00K.

Revenue (ttm)

$500.00K

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

31.23M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	500.00K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	28.83M	29.31M	-6,068.12%
Dec 31, 2021	-483.00K	-17.10M	-102.91%
Dec 31, 2020	16.61M	15.32M	1,181.87%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
UnitedHealth Group	435.16B
Johnson & Johnson	92.15B
Merck & Co.	64.24B
AbbVie	59.64B
Eli Lilly and Company	59.42B
AstraZeneca	58.13B
Novartis AG	56.37B
Novo Nordisk	49.58B

Revenue Rankings

XCUR News

4 weeks ago - Exicure, Inc. Reports Third Quarter 2025 Financial Results - GlobeNewsWire
4 weeks ago - New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting - GlobeNewsWire
6 weeks ago - Halper Sadeh LLC Encourages Exicure, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
2 months ago - Exicure Highlights Recent Achievements and Near-term Strategic Priorities - GlobeNewsWire
4 months ago - Exicure Posts Wider Loss in Fiscal Q2 - The Motley Fool
4 months ago - Exicure, Inc. Reports Second Quarter 2025 Financial Results - Business Wire
4 months ago - Exicure, Inc. (Nasdaq: XCUR) Regains Compliance with Nasdaq Filing Requirements - Business Wire
4 months ago - Exicure Completes the Last Patient, Last Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant - Business Wire

More News